84 results on '"Lage Maureen J"'
Search Results
2. The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
3. 1164-P: The Prevalence of Comorbidities among People with Obesity with and without Prediabetes
4. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study
5. The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database Analysis
6. Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data
7. Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018
8. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019
9. Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study
10. cost sharing, benefit design, and adherence: The case of multiple sclerosis
11. The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study
12. Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity
13. The Association Between Switching from Synthroid® and Clinical Outcomes: US Evidence from a Retrospective Database Analysis
14. The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes
15. The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database
16. The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database
17. 1033-P: Trends in U.S. Insulin Use for People with Diabetes: 2009-2017
18. 1161-P: Differences in U.S. Health Care Costs for Patients with Type 2 Diabetes: A Comparison Based upon HbA1c Thresholds
19. 938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes
20. Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents
21. Hypothyroidism Treatment Among Older Adults: Evidence from a Claims Database
22. Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database
23. Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
24. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes
25. Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting
26. Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-World Setting
27. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US
28. Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
29. Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population
30. Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion
31. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion
32. Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States
33. Outcomes of Medicaid Beneficiaries With Schizophrenia Receiving Clozapine Only or Antipsychotic Combinations
34. The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer
35. Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
36. Comparison of rates of and charges from pregnancy complications in users of extended and cyclic combined oral contraceptive (COC) regimens: a brief report
37. Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
38. Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report
39. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study
40. Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus
41. Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment
42. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study
43. Burden of a Multiple Sclerosis Relapse
44. Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer
45. Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts
46. A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine
47. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate
48. Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis
49. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge
50. Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.